267 related articles for article (PubMed ID: 23752505)
1. The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.
Xue J; Hoorelbeke B; Kagiampakis I; Demeler B; Balzarini J; Liwang PJ
Antimicrob Agents Chemother; 2013 Aug; 57(8):3976-89. PubMed ID: 23752505
[TBL] [Abstract][Full Text] [Related]
2. Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.
Fischer K; Nguyen K; LiWang PJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611356
[TBL] [Abstract][Full Text] [Related]
3. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.
Xue J; Gao Y; Hoorelbeke B; Kagiampakis I; Zhao B; Demeler B; Balzarini J; Liwang PJ
Mol Pharm; 2012 Sep; 9(9):2613-25. PubMed ID: 22827601
[TBL] [Abstract][Full Text] [Related]
4. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
[TBL] [Abstract][Full Text] [Related]
5. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
Alexandre KB; Gray ES; Pantophlet R; Moore PL; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
J Virol; 2011 Sep; 85(17):9039-50. PubMed ID: 21697467
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
Mori T; O'Keefe BR; Sowder RC; Bringans S; Gardella R; Berg S; Cochran P; Turpin JA; Buckheit RW; McMahon JB; Boyd MR
J Biol Chem; 2005 Mar; 280(10):9345-53. PubMed ID: 15613479
[TBL] [Abstract][Full Text] [Related]
7. Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains.
Férir G; Huskens D; Palmer KE; Boudreaux DM; Swanson MD; Markovitz DM; Balzarini J; Schols D
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1513-23. PubMed ID: 22607556
[TBL] [Abstract][Full Text] [Related]
8. Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.
Huang X; Jin W; Griffin GE; Shattock RJ; Hu Q
J Gen Virol; 2011 Oct; 92(Pt 10):2367-2373. PubMed ID: 21715597
[TBL] [Abstract][Full Text] [Related]
9. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
[TBL] [Abstract][Full Text] [Related]
10. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
11. Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.
Banerjee K; Michael E; Eggink D; van Montfort T; Lasnik AB; Palmer KE; Sanders RW; Moore JP; Klasse PJ
AIDS Res Hum Retroviruses; 2012 Feb; 28(2):206-14. PubMed ID: 21793733
[TBL] [Abstract][Full Text] [Related]
12. Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
Kagiampakis I; Gharibi A; Mankowski MK; Snyder BA; Ptak RG; Alatas K; LiWang PJ
Antimicrob Agents Chemother; 2011 Jan; 55(1):264-75. PubMed ID: 20956603
[TBL] [Abstract][Full Text] [Related]
13. Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.
Kramzer LF; Hamorsky KT; Graebing PW; Wang L; Fuqua JL; Matoba N; Lasnik AB; Moncla BJ; Zhang J; Palmer KE; Rohan LC
AAPS PharmSciTech; 2021 Feb; 22(3):83. PubMed ID: 33625602
[TBL] [Abstract][Full Text] [Related]
14. Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models.
Barton C; Kouokam JC; Lasnik AB; Foreman O; Cambon A; Brock G; Montefiori DC; Vojdani F; McCormick AA; O'Keefe BR; Palmer KE
Antimicrob Agents Chemother; 2014; 58(1):120-7. PubMed ID: 24145548
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.
Alexandre KB; Moore PL; Nonyane M; Gray ES; Ranchobe N; Chakauya E; McMahon JB; O'Keefe BR; Chikwamba R; Morris L
Virology; 2013 Nov; 446(1-2):66-76. PubMed ID: 24074568
[TBL] [Abstract][Full Text] [Related]
16. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential.
Lusvarghi S; Bewley CA
Viruses; 2016 Oct; 8(10):. PubMed ID: 27783038
[TBL] [Abstract][Full Text] [Related]
17. Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120.
Gopi H; Cocklin S; Pirrone V; McFadden K; Tuzer F; Zentner I; Ajith S; Baxter S; Jawanda N; Krebs FC; Chaiken IM
J Mol Recognit; 2009; 22(2):169-74. PubMed ID: 18498083
[TBL] [Abstract][Full Text] [Related]
18. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
[TBL] [Abstract][Full Text] [Related]
19. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.
O'Keefe BR; Vojdani F; Buffa V; Shattock RJ; Montefiori DC; Bakke J; Mirsalis J; d'Andrea AL; Hume SD; Bratcher B; Saucedo CJ; McMahon JB; Pogue GP; Palmer KE
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6099-104. PubMed ID: 19332801
[TBL] [Abstract][Full Text] [Related]
20. In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.
Andrianov AM; Nikolaev GI; Kornoushenko YV; Xu W; Jiang S; Tuzikov AV
Viruses; 2019 Aug; 11(8):. PubMed ID: 31412617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
